THE DEAL, AT A GLANCE
From the announcementHuayuan Gene
01What it doesHuayuan Gene is a Unclassified company focused on Predict Drug Efficacy | 36Kr Exclusive.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedHuayuan Gene raised Seed, announced 2026-07-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersHuayuan Gene's seed round thesis likely depends on whether its AI approach to replicating human cells can produce drug efficacy predictions that are useful enough for…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Huayuan Gene · Financing Record
Explore source-linked visual explanations for Huayuan Gene. Unsupported claims are withheld while source review continues.
Record 8597 · Recorded date: 2026-07-07
Explore company records →